A GENS-based approach to cardiovascular pharmacology: Impact on metabolism, pharmacokinetics and pharmacodynamics

Flavia Franconi, Ciriaco Carru, Ilaria Spoletini, Walter Malorni, Stefano Vella, Giuseppe Mercuro, Martino Deidda, Giuseppe Rosano

Research output: Contribution to journalArticle

Abstract

Pharmacological outcomes depend on many factors, with many of them being sexually dimorphic. Thus, physiological gender/sex (GENS) differences can influence pharmacokinetics, pharmacodynamics and, thus, bioavailability and resulting in efficacy of treatment, meaning GENS differences should be an important consideration in therapeutics. In particular, drug response can change according to different hormonal environments. Therefore, GENS-specific differences have a particular clinical relevance in terms of drug delivery, especially for those substances with a narrow therapeutic margin. Since adverse effects are more frequent among women, safety is a key issue. Overall, the status of women, from a pharmacological point of view, is often different and less studied than that of men and deserves particular attention. Further studies focused on women's responses to drugs are necessary in order to make optimal pharmacotherapeutic decisions.

Original languageEnglish
Pages (from-to)1437-1453
Number of pages17
JournalTherapeutic Delivery
Volume2
Issue number11
DOIs
Publication statusPublished - Nov 2011

Fingerprint

Sex Characteristics
Pharmacokinetics
Pharmacology
Pharmaceutical Preparations
Women's Rights
Biological Availability
Safety
Therapeutics

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

A GENS-based approach to cardiovascular pharmacology : Impact on metabolism, pharmacokinetics and pharmacodynamics. / Franconi, Flavia; Carru, Ciriaco; Spoletini, Ilaria; Malorni, Walter; Vella, Stefano; Mercuro, Giuseppe; Deidda, Martino; Rosano, Giuseppe.

In: Therapeutic Delivery, Vol. 2, No. 11, 11.2011, p. 1437-1453.

Research output: Contribution to journalArticle

Franconi, F, Carru, C, Spoletini, I, Malorni, W, Vella, S, Mercuro, G, Deidda, M & Rosano, G 2011, 'A GENS-based approach to cardiovascular pharmacology: Impact on metabolism, pharmacokinetics and pharmacodynamics', Therapeutic Delivery, vol. 2, no. 11, pp. 1437-1453. https://doi.org/10.4155/tde.11.117
Franconi, Flavia ; Carru, Ciriaco ; Spoletini, Ilaria ; Malorni, Walter ; Vella, Stefano ; Mercuro, Giuseppe ; Deidda, Martino ; Rosano, Giuseppe. / A GENS-based approach to cardiovascular pharmacology : Impact on metabolism, pharmacokinetics and pharmacodynamics. In: Therapeutic Delivery. 2011 ; Vol. 2, No. 11. pp. 1437-1453.
@article{21b4fb1f832d4db3a1ec530514e61918,
title = "A GENS-based approach to cardiovascular pharmacology: Impact on metabolism, pharmacokinetics and pharmacodynamics",
abstract = "Pharmacological outcomes depend on many factors, with many of them being sexually dimorphic. Thus, physiological gender/sex (GENS) differences can influence pharmacokinetics, pharmacodynamics and, thus, bioavailability and resulting in efficacy of treatment, meaning GENS differences should be an important consideration in therapeutics. In particular, drug response can change according to different hormonal environments. Therefore, GENS-specific differences have a particular clinical relevance in terms of drug delivery, especially for those substances with a narrow therapeutic margin. Since adverse effects are more frequent among women, safety is a key issue. Overall, the status of women, from a pharmacological point of view, is often different and less studied than that of men and deserves particular attention. Further studies focused on women's responses to drugs are necessary in order to make optimal pharmacotherapeutic decisions.",
author = "Flavia Franconi and Ciriaco Carru and Ilaria Spoletini and Walter Malorni and Stefano Vella and Giuseppe Mercuro and Martino Deidda and Giuseppe Rosano",
year = "2011",
month = "11",
doi = "10.4155/tde.11.117",
language = "English",
volume = "2",
pages = "1437--1453",
journal = "Therapeutic Delivery",
issn = "2041-5990",
publisher = "Future Science",
number = "11",

}

TY - JOUR

T1 - A GENS-based approach to cardiovascular pharmacology

T2 - Impact on metabolism, pharmacokinetics and pharmacodynamics

AU - Franconi, Flavia

AU - Carru, Ciriaco

AU - Spoletini, Ilaria

AU - Malorni, Walter

AU - Vella, Stefano

AU - Mercuro, Giuseppe

AU - Deidda, Martino

AU - Rosano, Giuseppe

PY - 2011/11

Y1 - 2011/11

N2 - Pharmacological outcomes depend on many factors, with many of them being sexually dimorphic. Thus, physiological gender/sex (GENS) differences can influence pharmacokinetics, pharmacodynamics and, thus, bioavailability and resulting in efficacy of treatment, meaning GENS differences should be an important consideration in therapeutics. In particular, drug response can change according to different hormonal environments. Therefore, GENS-specific differences have a particular clinical relevance in terms of drug delivery, especially for those substances with a narrow therapeutic margin. Since adverse effects are more frequent among women, safety is a key issue. Overall, the status of women, from a pharmacological point of view, is often different and less studied than that of men and deserves particular attention. Further studies focused on women's responses to drugs are necessary in order to make optimal pharmacotherapeutic decisions.

AB - Pharmacological outcomes depend on many factors, with many of them being sexually dimorphic. Thus, physiological gender/sex (GENS) differences can influence pharmacokinetics, pharmacodynamics and, thus, bioavailability and resulting in efficacy of treatment, meaning GENS differences should be an important consideration in therapeutics. In particular, drug response can change according to different hormonal environments. Therefore, GENS-specific differences have a particular clinical relevance in terms of drug delivery, especially for those substances with a narrow therapeutic margin. Since adverse effects are more frequent among women, safety is a key issue. Overall, the status of women, from a pharmacological point of view, is often different and less studied than that of men and deserves particular attention. Further studies focused on women's responses to drugs are necessary in order to make optimal pharmacotherapeutic decisions.

UR - http://www.scopus.com/inward/record.url?scp=80054920376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054920376&partnerID=8YFLogxK

U2 - 10.4155/tde.11.117

DO - 10.4155/tde.11.117

M3 - Article

C2 - 22826875

AN - SCOPUS:80054920376

VL - 2

SP - 1437

EP - 1453

JO - Therapeutic Delivery

JF - Therapeutic Delivery

SN - 2041-5990

IS - 11

ER -